|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/19 | (2006.01) |
| A61K 47/38 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61K 31/496 | (2006.01) |
| (11) | Number of the document | 1675573 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04795514.1 |
| Date of filing the European patent application | 2004-10-18 | |
| (97) | Date of publication of the European application | 2006-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2008-10-22 |
| (46) | Date of publication of the claims translation | 2009-02-25 |
| (86) | Number | PCT/US2004/034367 |
| Date | 2004-10-18 |
| (87) | Number | WO 2005/041937 |
| Date | 2005-05-12 |
| (30) | Number | Date | Country code |
| 513618 P | 2003-10-23 | US |
| (72) |
KOSTANSKI, Janusz W., US
MATSUDA, Takakuni Corpo Faburesu B-201, JP
NERURKAR, Manoj, US
NARINGREKAR, Vijay H., US
|
| (73) |
OTSUKA PHARMACEUTICAL CO., LTD.,
2-9 Kanda Tsukasa-cho Chiyoda-ku, Tokyo 101-8535,
JP
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kontroliuojamo atpalaidavimo sterili injekuojama aripiprazolo vaisto forma ir būdas |
| CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD |
| Payment date | Validity (years) | Amount | |
| 2023-09-25 | 347.00 EUR |